Rectal Cancer: Chemo Matches Radiation

摘要

Results from the phase II/III PROSPECT trial show that neoadjuvant chemotherapy works just as well as pelvic radiation for patients with locally advanced rectal cancer. Five-year disease-free survival, overall survival, and recurrence rates were almost identical for the two approaches.